You can buy or sell MITO and other stocks, options, and ETFs commission-free!
Stealth BioTherapeutics Corp. ADS, also called Stealth BioTherapeutics, is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Read More The company was founded on April 3, 2006 and is headquartered in Newton, MA. The listed name for MITO is Stealth BioTherapeutics Corp. ADS.
52 Week High
52 Week Low
— per share
Expected Nov 12, Pre-Market